Pharmacovigilance
Pharmacovigilance is the scientific discipline comprising systematic detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem associated with pharmaceutical products in clinical use.
22.9K
Publications
1.4M
Citations
106.2K
Authors
13.3K
Institutions
Publications per year
2017–2026
7.6K
22.9K
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5.1K citations · Full text
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ · 2004 · 3.2K citations · Full text
1–5 of 22.9K
106.2K
55
h-index
40
h-index
39
h-index
37
h-index
36
h-index
1–5 of 106.2K
13.3K

Brigham and Women's Hospital
Boston, United States
120 h-index
1.4K publications
212.1K citations
Harvard University
Cambridge, United States
112 h-index
1.4K publications
177.3K citations
Inserm
Paris, France
96 h-index
2.2K publications
159.4K citations

University of Toronto
Toronto, Canada
92 h-index
733 publications
160.7K citations
University College London
London, United Kingdom
76 h-index
846 publications
134.4K citations

Karolinska Institutet
Stockholm, Sweden
74 h-index
778 publications
48.2K citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
74 h-index
483 publications
39.5K citations
Pfizer (United States)
New York, United States
74 h-index
1.1K publications
73.5K citations
1–8 of 13.3K
189 publications · 30.7K citations
102
h-index
240 publications · 65K citations
102
h-index
Repository · 1.2K publications · 48.7K citations
90
h-index
BJCP · 473 publications · 27.8K citations
83
h-index
NEJM · 121 publications · 68K citations
81
h-index
1–5